X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Karuturi Global - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs KARUTURI GLOBAL - Comparison Results

KARUTURI GLOBAL 
   Change

Karuturi Global (KGL), based in Bangalore, and having operations in Kenya and Ethiopia, is the world's largest producer of cut roses. The company's total capacity currently stands at around 700 m stems per annum. It cultivates 10 hectares of rose far... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES KARUTURI GLOBAL AMAR REMEDIES/
KARUTURI GLOBAL
 
P/E (TTM) x -0.5 3.4 - View Chart
P/BV x 0.1 0.1 103.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 AMAR REMEDIES   KARUTURI GLOBAL
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
KARUTURI GLOBAL
Mar-14
AMAR REMEDIES/
KARUTURI GLOBAL
5-Yr Chart
Click to enlarge
High Rs1644 4,315.8%   
Low Rs861 14,333.3%   
Sales per share (Unadj.) Rs261.66.1 4,296.5%  
Earnings per share (Unadj.) Rs17.40.9 2,038.2%  
Cash flow per share (Unadj.) Rs22.31.3 1,671.1%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs100.723.0 438.2%  
Shares outstanding (eoy) m26.16809.73 3.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.50.4 132.2%   
Avg P/E ratio x7.22.6 278.8%  
P/CF ratio (eoy) x5.61.6 340.0%  
Price / Book Value ratio x1.20.1 1,296.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,2701,781 183.6%   
No. of employees `000NANA-   
Total wages/salary Rs m163343 47.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,8444,931 138.8%  
Other income Rs m21244 8.6%   
Total revenues Rs m6,8655,175 132.7%   
Gross profit Rs m1,1311,259 89.8%  
Depreciation Rs m128389 32.9%   
Interest Rs m398726 54.8%   
Profit before tax Rs m626388 161.2%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m0-136 0.0%   
Extraordinary Inc (Exp) Rs m-50204 -24.5%   
Tax Rs m121-235 -51.4%   
Profit after tax Rs m455691 65.8%  
Gross profit margin %16.525.5 64.7%  
Effective tax rate %19.3-60.6 -31.9%   
Net profit margin %6.614.0 47.4%  
BALANCE SHEET DATA
Current assets Rs m4,9043,811 128.7%   
Current liabilities Rs m3,5816,763 53.0%   
Net working cap to sales %19.3-59.9 -32.3%  
Current ratio x1.40.6 243.0%  
Inventory Days Days12416 783.3%  
Debtors Days Days100124 80.9%  
Net fixed assets Rs m1,68926,264 6.4%   
Share capital Rs m262810 32.4%   
"Free" reserves Rs m2,35815,785 14.9%   
Net worth Rs m2,63518,613 14.2%   
Long term debt Rs m5074,976 10.2%   
Total assets Rs m6,86230,598 22.4%  
Interest coverage x2.61.5 167.6%   
Debt to equity ratio x0.20.3 72.0%  
Sales to assets ratio x1.00.2 618.9%   
Return on assets %12.44.6 268.4%  
Return on equity %17.33.7 465.1%  
Return on capital %31.05.0 618.6%  
Exports to sales %4.00.9 452.1%   
Imports to sales %00-   
Exports (fob) Rs m27344 627.6%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m27344 627.6%   
Fx outflow Rs m20 5,000.0%   
Net fx Rs m27143 623.6%   
CASH FLOW
From Operations Rs m-3134,367 -7.2%  
From Investments Rs m-489-3,984 12.3%  
From Financial Activity Rs m769-255 -301.7%  
Net Cashflow Rs m-33129 -25.2%  

Share Holding

Indian Promoters % 25.5 5.5 463.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 0.2 4,600.0%  
FIIs % 0.0 15.8 -  
ADR/GDR % 0.0 1.3 -  
Free float % 65.3 77.2 84.6%  
Shareholders   13,061 70,503 18.5%  
Pledged promoter(s) holding % 99.7 22.4 445.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   HIND. UNILEVER  P&G HYGIENE  LINC PEN & PLASTICS LTD  BATA INDIA  COLGATE  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Finishes on a Flat Note; Novartis India Rallies 7%(Closing)

Indian share markets continued to trade range bound in afternoon session with market participants awaiting the US Federal Reserve's policy statement this week.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

The Recipe to Over 60% Returns in Less Than a Year(The 5 Minute Wrapup)

Sep 9, 2017

Short term crisis in some companies could unveil some great investing opportunities.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS